Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (225) Arrow Down
Filter Results: (225) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (225)
    • People  (2)
    • News  (71)
    • Research  (151)
    • Multimedia  (1)
  • Faculty Publications  (57)

Show Results For

  • All HBS Web  (225)
    • People  (2)
    • News  (71)
    • Research  (151)
    • Multimedia  (1)
  • Faculty Publications  (57)
← Page 8 of 225 Results →
  • 16 Oct 2013
  • Op-Ed

Response to Readers: Combating Climate Change with Nuclear Power and Fracking

With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
Keywords: by Joe Lassiter; Energy; Utilities
  • 23 Mar 2010
  • First Look

First Look: March 23

Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
  • 22 Aug 2006
  • First Look

First Look: August 22, 2006

805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace
  • 14 Jul 2006
  • Op-Ed

The Case for Consumer-Driven Medicaid

diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow... View Details
Keywords: by Regina E. Herzlinger
  • 01 Mar 2019
  • News

The Blue-Green Revolution

breakthrough finally provides a line of sight to a scalable algae biofuel. The company is already growing algae in outdoor ponds at a test facility near California’s Salton Sea, and Fetzer envisions a day when large pools of algae will be... View Details
Keywords: Alexander Gelfand; illustration by Eric Nyquist
  • 27 Mar 2012
  • First Look

First Look: March 27

Prima facie, it is unclear whether media outlets are favoring their own authors because these are the authors that their readers prefer or simply because they are trying to collude. We provide a test to distinguish between these two... View Details
Keywords: Carmen Nobel
  • 30 Mar 2010
  • First Look

First Look: March 30

Daniel Kahneman, 217-247. New York: Oxford University Press, 2010. Abstract We test for whether, once "basic needs" are satisfied, there is happiness adaptation to further gains in income using three data sets. Individual German... View Details
Keywords: Sean Silverthorne
  • 27 Feb 2018
  • First Look

First Look at New Research and Ideas, February 27, 2018

prevention-focused questions. We demonstrate that every additional prevention-focused question significantly hinders the entrepreneur's ability to raise capital, fully mediating gender's effect on funding. By experimentally testing an... View Details
Keywords: Sean Silverthorne
  • 15 Apr 2014
  • First Look

First Look: April 15

from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative... View Details
Keywords: Sean Silverthorne
  • 12 Jan 2016
  • First Look

January 12, 2016

approximation of a fully sequential test for the maximum hazard ratio of the drug over multiple adverse events. A numerical study verifies that our method delivers Type I /II errors that are below... View Details
Keywords: Carmen Nobel
  • 22 May 2020
  • In Practice

Post-COVID Health Care: More Screens, Less Red Tape?

The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers worldwide set up drive-through View Details
Keywords: by Danielle Kost
  • 28 Jul 2015
  • First Look

First Look: July 28, 2015

country-level factors that limit firms' use of selective disclosure by intensifying scrutiny on them and by diffusing global norms to their headquarters countries. We test our hypotheses using a novel panel dataset of 4,750 public... View Details
Keywords: Carmen Nobel
  • 12 Feb 2019
  • First Look

New Research and Ideas, February 12, 2019

Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
  • 30 Oct 2007
  • First Look

First Look: October 30, 2007

Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
  • 26 Jun 2000
  • Research & Ideas

What’s an Internet Business Model? Ask a Health Care Professional

process of testing drugs and bringing them to market. No matter how ingenious a business model may appear, however, all panelists agreed that the trust of patients remains paramount. Patient trust, then,... View Details
Keywords: by Martha Lagace; Health
  • 08 Jan 2008
  • First Look

First Look: January 8, 2008

Abstract We use oil price fluctuations to construct a new instrument to test the impact of transfers from wealthy OPEC nations to their poorer Muslim allies. The instrument identifies plausibly exogenous variation in foreign aid. We... View Details
Keywords: Martha Lagace
  • 01 Dec 2020
  • News

Quantum Leap

process of drug development: With quantum’s ability to analyze multiple molecules, proteins, and chemicals at the same time, researchers could significantly speed the time to market with ultrafast and high-volume testing—and discover new... View Details
Keywords: Jen McFarland Flint; Computer and Electronic Product Manufacturing; Manufacturing
  • 18 Apr 2017
  • First Look

First Look at New Ideas, April 18

M&A) and Werner Baumann (CFO) have to decide whether to increase the cash portion of their $14.2 billion offer and/or amend the terms of a proposed joint venture (JV) with Merck involving cardiovascular drugs that had been included in... View Details
Keywords: by Sean Silverthorne
  • 30 Jun 2003
  • Research & Ideas

Computer Security is For Managers, Too

each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
Keywords: by Robert D. Austin & Christopher A.R. Darby
  • 24 May 2011
  • First Look

First Look: May 24

perspective that Porter has taken, often as a result of his specific background and prior research interests. The chapter then turns to extensions of these core concepts in Porter's more recent work. A central focus of this work has been the creation of broad-based... View Details
Keywords: Sean Silverthorne
  • ←
  • 8
  • 9
  • 10
  • 11
  • 12
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.